Early endovascular experience for treatments of Takayasu's arteritis

Tsung Hsing Lee, I. Ming Chen, Wei Yuan Chen, Chi Feng Weng, Chiao Po Hsu, Chun Che Shih

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Takayasu's arteritis (TA) is a chronic inflammatory disease that involves the aorta and its major branches; however, only limited data are available on TA in Taiwan. This study presents the clinical features, angiographic findings, and response to treatment of patients with TA at a single institute in Taiwan. Methods: A search of the hospital database for ICD9 code 446.7 (Takayasu's disease) between 1990 and 2010 was performed. Seven cases fulfilled the 1990 American College of Rheumatology diagnostic criteria for Takayasu's disease. Angiographic classification was made according to the guidelines of the 1994 International TA Conference in Tokyo. Results: All of our cases were female, and the median age at diagnosis was 27.5 years (range 14-36 years). Four patients had an angiographic classification of type I (57.1%), two were classified as type V (28.6%), and one was classified as type III (14.3%). The most common symptoms/signs were dizziness and vascular bruits. Two patients underwent bypass surgery, four endovascular stenting, and one hybrid bypass with stenting. After a mean follow-up period of 50.3 ± 68.2 months (range 12.3-199.6 months), both the procedure success and survival rates were 100%. There were four restenosis cases (57.1%), one in the surgical bypass group without symptoms (33.3%), and three in the endovascular group (60%), five restenosis in 14 stents (35.7%). Also, these three patients received secondary endovascular procedure for percutaneous transluminal angioplasty or restenting. Conclusion: There have not been any case series reports about treatments of Takayasu's disease in Taiwan to date, based on a search of the PubMed/MEDLINE and Cochrane Library databases. Although endovascular treatment is becoming more prevalent, the restenosis rate is still high, and long-term follow-up and further strategy for restenosis management are the main challenges.

Original languageEnglish
Pages (from-to)83-87
Number of pages5
JournalJournal of the Chinese Medical Association
Volume76
Issue number2
DOIs
Publication statusPublished - Feb 1 2013
Externally publishedYes

Fingerprint

Takayasu Arteritis
Taiwan
Therapeutics
Databases
Endovascular Procedures
Tokyo
Dizziness
Angioplasty
PubMed
MEDLINE
Libraries
Signs and Symptoms
Stents
Blood Vessels
Aorta
Chronic Disease
Survival Rate
Guidelines

Keywords

  • Bypass
  • Endovascular stenting
  • Takayasu's arteritis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Early endovascular experience for treatments of Takayasu's arteritis. / Lee, Tsung Hsing; Chen, I. Ming; Chen, Wei Yuan; Weng, Chi Feng; Hsu, Chiao Po; Shih, Chun Che.

In: Journal of the Chinese Medical Association, Vol. 76, No. 2, 01.02.2013, p. 83-87.

Research output: Contribution to journalArticle

Lee, Tsung Hsing ; Chen, I. Ming ; Chen, Wei Yuan ; Weng, Chi Feng ; Hsu, Chiao Po ; Shih, Chun Che. / Early endovascular experience for treatments of Takayasu's arteritis. In: Journal of the Chinese Medical Association. 2013 ; Vol. 76, No. 2. pp. 83-87.
@article{cdc99fd3e297424b9c14a2e6c63e7b3b,
title = "Early endovascular experience for treatments of Takayasu's arteritis",
abstract = "Background: Takayasu's arteritis (TA) is a chronic inflammatory disease that involves the aorta and its major branches; however, only limited data are available on TA in Taiwan. This study presents the clinical features, angiographic findings, and response to treatment of patients with TA at a single institute in Taiwan. Methods: A search of the hospital database for ICD9 code 446.7 (Takayasu's disease) between 1990 and 2010 was performed. Seven cases fulfilled the 1990 American College of Rheumatology diagnostic criteria for Takayasu's disease. Angiographic classification was made according to the guidelines of the 1994 International TA Conference in Tokyo. Results: All of our cases were female, and the median age at diagnosis was 27.5 years (range 14-36 years). Four patients had an angiographic classification of type I (57.1{\%}), two were classified as type V (28.6{\%}), and one was classified as type III (14.3{\%}). The most common symptoms/signs were dizziness and vascular bruits. Two patients underwent bypass surgery, four endovascular stenting, and one hybrid bypass with stenting. After a mean follow-up period of 50.3 ± 68.2 months (range 12.3-199.6 months), both the procedure success and survival rates were 100{\%}. There were four restenosis cases (57.1{\%}), one in the surgical bypass group without symptoms (33.3{\%}), and three in the endovascular group (60{\%}), five restenosis in 14 stents (35.7{\%}). Also, these three patients received secondary endovascular procedure for percutaneous transluminal angioplasty or restenting. Conclusion: There have not been any case series reports about treatments of Takayasu's disease in Taiwan to date, based on a search of the PubMed/MEDLINE and Cochrane Library databases. Although endovascular treatment is becoming more prevalent, the restenosis rate is still high, and long-term follow-up and further strategy for restenosis management are the main challenges.",
keywords = "Bypass, Endovascular stenting, Takayasu's arteritis",
author = "Lee, {Tsung Hsing} and Chen, {I. Ming} and Chen, {Wei Yuan} and Weng, {Chi Feng} and Hsu, {Chiao Po} and Shih, {Chun Che}",
year = "2013",
month = "2",
day = "1",
doi = "10.1016/j.jcma.2012.10.006",
language = "English",
volume = "76",
pages = "83--87",
journal = "Journal of the Chinese Medical Association",
issn = "1726-4901",
publisher = "Elsevier Taiwan LLC",
number = "2",

}

TY - JOUR

T1 - Early endovascular experience for treatments of Takayasu's arteritis

AU - Lee, Tsung Hsing

AU - Chen, I. Ming

AU - Chen, Wei Yuan

AU - Weng, Chi Feng

AU - Hsu, Chiao Po

AU - Shih, Chun Che

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Background: Takayasu's arteritis (TA) is a chronic inflammatory disease that involves the aorta and its major branches; however, only limited data are available on TA in Taiwan. This study presents the clinical features, angiographic findings, and response to treatment of patients with TA at a single institute in Taiwan. Methods: A search of the hospital database for ICD9 code 446.7 (Takayasu's disease) between 1990 and 2010 was performed. Seven cases fulfilled the 1990 American College of Rheumatology diagnostic criteria for Takayasu's disease. Angiographic classification was made according to the guidelines of the 1994 International TA Conference in Tokyo. Results: All of our cases were female, and the median age at diagnosis was 27.5 years (range 14-36 years). Four patients had an angiographic classification of type I (57.1%), two were classified as type V (28.6%), and one was classified as type III (14.3%). The most common symptoms/signs were dizziness and vascular bruits. Two patients underwent bypass surgery, four endovascular stenting, and one hybrid bypass with stenting. After a mean follow-up period of 50.3 ± 68.2 months (range 12.3-199.6 months), both the procedure success and survival rates were 100%. There were four restenosis cases (57.1%), one in the surgical bypass group without symptoms (33.3%), and three in the endovascular group (60%), five restenosis in 14 stents (35.7%). Also, these three patients received secondary endovascular procedure for percutaneous transluminal angioplasty or restenting. Conclusion: There have not been any case series reports about treatments of Takayasu's disease in Taiwan to date, based on a search of the PubMed/MEDLINE and Cochrane Library databases. Although endovascular treatment is becoming more prevalent, the restenosis rate is still high, and long-term follow-up and further strategy for restenosis management are the main challenges.

AB - Background: Takayasu's arteritis (TA) is a chronic inflammatory disease that involves the aorta and its major branches; however, only limited data are available on TA in Taiwan. This study presents the clinical features, angiographic findings, and response to treatment of patients with TA at a single institute in Taiwan. Methods: A search of the hospital database for ICD9 code 446.7 (Takayasu's disease) between 1990 and 2010 was performed. Seven cases fulfilled the 1990 American College of Rheumatology diagnostic criteria for Takayasu's disease. Angiographic classification was made according to the guidelines of the 1994 International TA Conference in Tokyo. Results: All of our cases were female, and the median age at diagnosis was 27.5 years (range 14-36 years). Four patients had an angiographic classification of type I (57.1%), two were classified as type V (28.6%), and one was classified as type III (14.3%). The most common symptoms/signs were dizziness and vascular bruits. Two patients underwent bypass surgery, four endovascular stenting, and one hybrid bypass with stenting. After a mean follow-up period of 50.3 ± 68.2 months (range 12.3-199.6 months), both the procedure success and survival rates were 100%. There were four restenosis cases (57.1%), one in the surgical bypass group without symptoms (33.3%), and three in the endovascular group (60%), five restenosis in 14 stents (35.7%). Also, these three patients received secondary endovascular procedure for percutaneous transluminal angioplasty or restenting. Conclusion: There have not been any case series reports about treatments of Takayasu's disease in Taiwan to date, based on a search of the PubMed/MEDLINE and Cochrane Library databases. Although endovascular treatment is becoming more prevalent, the restenosis rate is still high, and long-term follow-up and further strategy for restenosis management are the main challenges.

KW - Bypass

KW - Endovascular stenting

KW - Takayasu's arteritis

UR - http://www.scopus.com/inward/record.url?scp=84872685282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872685282&partnerID=8YFLogxK

U2 - 10.1016/j.jcma.2012.10.006

DO - 10.1016/j.jcma.2012.10.006

M3 - Article

C2 - 23351418

AN - SCOPUS:84872685282

VL - 76

SP - 83

EP - 87

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

SN - 1726-4901

IS - 2

ER -